Methods and compositions for the treatment of a host with a cellular proliferative disease
CA 2180260 A1 · Owner: Matrix Pharmaceutical, Inc. · Inventors: Michaels, Shawnya J.; Jones, Richard E.; Maskiewicz, Richard
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods and compositions are provided for the treatment of a hostwith a cellular proliferative disease particularly a neoplasia. In the subject methods a pharmaceutically acceptable, substantially anhydrous injectable semi-solid composition which acts as a depot for a cytostatic agent, is administered to a lesion of the disease particularly intralesionally. The subject compositions comprise a water immiscible, fatty acid ester matrix and a cytostatic agent.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 28, 1994. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 28, 2014.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 28, 2016.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.